Monday, April 12, 2021

Advertising

Home Business News Bristol Myers Squibb Announces Accepted Amounts and Pricing Terms of Tender Offers...

Bristol Myers Squibb Announces Accepted Amounts and Pricing Terms of Tender Offers for an Aggregate …


NEW YORK–()–Bristol-Myers Squibb Company (NYSE:BMY) (“Bristol Myers Squibb”), with its wholly-owned subsidiary Celgene Corporation (“Celgene”) (collectively, the “Offerors”), announced the accepted amounts and pricing terms of their previously announced 20 separate offers to purchase for cash notes issued by the Offerors listed in the tables below for up to an aggregate purchase price of $4.0 billion.

The table below indicates, among other things, the aggregate principal amount of Notes tendered as of 5:00 p.m. (New York City time) on February 18, 2021 (the “Early Tender Deadline”) and accepted in each Offer, the Offer Yield (each as defined below), the proration factor, if any, and the total…



Click here to view the original article.

- Advertisment -
- Advertisment -

Recently Viewed

You might also like ...

ANZ’s VC arm looks to loyalty and snubs BNPL
Matt Kay’s Beach Energy hunting for gas amid fears of south-east shortfall